Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Genomic Vision Launches Fibersmart, AI-powered Software For Automating Genomic Analysis

  • Seamless user experience offering up to three times more precision and ten times faster analysis than our previous software

  • The platform has already been successfully tested by AstraZeneca and the Fritz Lipmann Institute

  • Proprietary DNA combing technique offers multiple potential applications including in cell and gene therapy quality control

Genomic Vision, a Euronext-listed biotechnology company that develops products and services dedicated to the analyses and control of changes in the genome, announces the launch of FiberSmart, an innovative, Artificial Intelligence (AI)-based technology aimed at automating the detection and quantification of fluorescent signals on combed DNA molecules.

AiThority Interview : AiThority Interview with Lori Anne, Director of Product Development & Management at Verizon

Initially, FiberSmart will be available for the analysis of Replication Combing Assays (RCA), Genomic Vision’s proprietary method for the direct visualization of DNA replication kinetics at the single molecule level. The software leverages advanced AI methods to visualize, detect and analyze DNA replication kinetics up to three times more accurately and up to ten times faster than Genomic Vision’s existing software solutions.

Related Posts
1 of 40,931

Ergonomically designed, FiberSmart offers a simple and user-friendly interface, allowing fast analysis of DNA replication signals to deduce essential parameters describing replication kinetics. The technology was successfully tested and validated by AstraZeneca (LSE/STO/Nasdaq: AZN), and the Fritz Lipmann Institute, Germany.

Read More InterviewAiThority Interview with Mario Ciabarra, Founder and CEO of Quantum Metric

The software is compatible with Genomic Vision’s suite of scanners FiberVision and FiberVision-S for the RCA assay of the Company’s proprietary DNA combing technology, which has multiple potential applications including in cell and gene therapy quality control.

Aaron Bensimon, Chief Executive Officer of Genomic Vision commented: “The launch of FiberSmart is an important milestone for Genomic Vision as we bring the benefits of powerful AI technology to our users, who can now perform faster and more accurate genomic analysis seamlessly. Our proprietary DNA combing technique has multiple potential applications, particularly in the cell and gene therapy space, where highly accurate genomic analysis is paramount to ensure robust quality standards are met. With the launch of this software we are making it easier for users to exploit the full potential of our proprietary advanced genomic analysis technique.”

Comments are closed.